通过专为投资者打造的一站式数据看板，全面查看 4D Molecular Therapeutics Inc 的财务状况。平台将复杂的财务报表整理为可自定义的视图，助您更轻松地进行财务分析。您可以查看最新年度财务报告，也可以通过利润表、资产负债表和现金流量表，按季度分析公司表现。借助实时财务指标，持续追踪公司的经营状况和市场表现更加便捷。

关键财务比率

总市值

769.04M

股息TTM

0.00

市盈率 TTM

-5.73

每股收益TTM

-2.57

营业收入

85.21M

净利润

-160.87M

净资产收益率

-34.92%

总资产收益率

-31.28%

4D Molecular Therapeutics Inc 财报日历

财务报表摘要

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

财务指标

每股收益

-6.20%-1.04

-17.39%-1.01

133.99%0.30

-28.41%-1.01

-54.57%-0.98

-30.87%-0.86

---0.89

-225.16%-0.79

18.16%-0.63

24.97%-0.66

----

---0.24

---0.77

---0.88

---0.84

---2.48

----

营业收入

25106.67%3.78M

21664.29%3.05M

8508900.00%85.09M

2900.00%90.00K

200.00%15.00K

-50.00%14.00K

--1.00K

-99.99%3.00K

-97.91%5.00K

-90.60%28.00K

----

3940.80%20.20M

47.53%239.00K

-75.55%298.00K

1255.43%1.25M

-63.40%500.00K

-98.89%162.00K

-39.05%1.22M

--92.00K

--1.37M

--14.58M

净利润

-33.44%-72.94M

-43.33%-68.76M

139.05%19.40M

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

----

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

利润率

99.47%-1929.01%

99.34%-2256.65%

100.00%22.80%

95.68%-63195.56%

47.87%-364386.67%

-196.11%-342657.14%

---4967100.00%

-2878877.80%-1461433.33%

-5541.39%-699060.00%

-1102.28%-115717.86%

----

---50.76%

---12391.63%

---9624.83%

---2195.59%

---4256.91%

----

毛利率

0.00%100.00%

--100.00%

0.00%100.00%

----

--100.00%

----

资产负债率

--3.98%

----

--0.00%

----

--0.00%

----

利润表

营业收入

25106.67%3.78M

21664.29%3.05M

8508900.00%85.09M

2900.00%90.00K

200.00%15.00K

-50.00%14.00K

--1.00K

-99.99%3.00K

-97.91%5.00K

-90.60%28.00K

----

3940.80%20.20M

47.53%239.00K

-75.55%298.00K

1255.43%1.25M

-63.40%500.00K

-98.89%162.00K

-39.05%1.22M

--92.00K

--1.37M

--14.58M

营业利润

-29.55%-77.03M

-37.30%-73.62M

126.22%14.71M

-19.66%-61.19M

-40.04%-59.46M

-40.60%-53.62M

---56.12M

-265.91%-51.13M

-32.11%-42.46M

-26.67%-38.14M

----

47.26%-13.97M

-13.05%-32.14M

-14.07%-30.11M

-15.97%-28.72M

-16.92%-26.50M

-274.22%-28.43M

-61.79%-26.39M

---24.76M

---22.66M

---7.60M

净利润

-33.44%-72.94M

-43.33%-68.76M

139.05%19.40M

-29.73%-56.88M

-56.38%-54.66M

-48.06%-47.97M

---49.67M

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.40M

----

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-9.15%-27.38M

-15.52%-25.69M

-270.09%-28.09M

-60.54%-26.34M

---25.08M

---22.24M

---7.59M

资产负债表

流动资产

26.27%382.96M

21.89%405.36M

-5.01%413.13M

-38.84%312.38M

-45.12%303.29M

-37.91%332.57M

46.65%434.93M

55.60%510.76M

73.91%552.63M

158.69%535.59M

34.50%296.59M

41.19%328.24M

28.90%317.78M

-14.81%207.04M

-13.96%220.51M

40.27%232.48M

-0.90%246.52M

-8.11%243.05M

-9.33%256.28M

79.10%165.73M

----

流动负债总额

37.48%47.67M

61.36%43.40M

50.90%43.98M

25.94%37.11M

78.72%34.68M

63.99%26.90M

53.81%29.15M

62.23%29.46M

41.12%19.40M

45.44%16.40M

20.47%18.95M

33.91%18.16M

-4.06%13.75M

-6.72%11.28M

-3.72%15.73M

19.26%13.56M

45.20%14.33M

-13.11%12.09M

-2.42%16.34M

-20.35%11.37M

----

总资产

4.01%492.62M

-0.55%512.90M

1.13%566.71M

-29.81%423.98M

-23.62%473.64M

-18.12%515.73M

64.87%560.38M

67.04%604.03M

75.92%620.12M

158.13%629.88M

29.81%339.89M

29.07%361.61M

16.36%352.50M

-24.90%244.02M

-25.92%261.85M

16.44%280.16M

18.83%302.94M

20.29%324.93M

22.60%353.49M

145.05%240.62M

----

总负债

61.06%84.96M

32.74%61.07M

22.64%61.05M

7.67%55.00M

65.99%52.75M

56.89%46.01M

55.26%49.78M

61.24%51.08M

16.15%31.78M

15.38%29.32M

5.09%32.06M

10.30%31.68M

-10.06%27.36M

-11.97%25.41M

-11.26%30.51M

74.23%28.72M

112.90%30.42M

4.29%28.87M

7.63%34.38M

-41.20%16.48M

----

总权益

-3.14%407.66M

-3.81%451.84M

-0.97%505.66M

-33.27%368.98M

-28.46%420.89M

-21.79%469.72M

65.87%510.61M

67.59%552.95M

80.95%588.34M

174.72%600.56M

33.07%307.83M

31.22%329.93M

19.31%325.14M

-26.16%218.61M

-27.50%231.34M

12.18%251.44M

13.24%272.52M

22.12%296.06M

24.46%319.11M

219.48%224.13M

----

现金流量表

经营净额

-61.37%-70.00M

-42.65%-68.13M

162.25%28.55M

-58.20%-46.50M

-43.43%-43.38M

-64.18%-47.76M

-86.06%-45.86M

-2409.91%-29.39M

-37.06%-30.24M

-4.24%-29.09M

-10.97%-24.65M

94.43%-1.17M

-10.86%-22.07M

-18.50%-27.91M

-1.73%-22.21M

-33.69%-21.02M

-22.83%-19.90M

-53.20%-23.55M

-24.78%-21.84M

---15.72M

----

投资净额

284.41%25.54M

115.63%68.89M

-1925.29%-128.85M

-34.88%17.78M

81.16%-13.85M

112.14%31.95M

205.64%7.06M

-8.94%27.30M

-249.20%-73.54M

-710.38%-263.26M

81.32%-6.68M

95.05%29.98M

-14.23%49.29M

179.71%43.13M

-10.80%-35.78M

111.06%15.37M

7897.56%57.47M

-8328.35%-54.11M

-6256.50%-32.29M

---139.01M

----

融资净额

4811.72%42.34M

--11.48M

18532.61%111.98M

-79.58%116.00K

-95.00%862.00K

----

-87.38%601.00K

-94.62%568.00K

-86.78%17.25M

2800.05%318.83M

132.75%4.76M

2195.00%10.56M

261138.00%130.52M

1647.85%10.99M

-98.24%2.05M

-76.73%460.00K

-106.10%-50.00K

174.26%629.00K

-43.62%116.14M

--1.98M

----

营业收入

业务

报告期:

暂无数据

地区

报告期:

暂无数据

常见问题

4D Molecular Therapeutics Inc的总收入是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，总收入达到了85.21M（同比变化37.00K）。

4D Molecular Therapeutics Inc的流动资产是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，流动资产为413.13M（同比变化-5.01）。

4D Molecular Therapeutics Inc的总资产是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，4D Molecular Therapeutics Inc的总资产为566.71M（同比变化1.13）。

4D Molecular Therapeutics Inc的总负债是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，4D Molecular Therapeutics Inc的总负债为61.05M（同比变化22.64）。

4D Molecular Therapeutics Inc的总权益是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，4D Molecular Therapeutics Inc的总权益为505.66M（同比变化-0.97）。

4D Molecular Therapeutics Inc的净营业收入是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，4D Molecular Therapeutics Inc的净营业收入为-159.55M（同比变化15.06）。

4D Molecular Therapeutics Inc的净投资是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，4D Molecular Therapeutics Inc的净投资为-92.97M（同比变化69.26）。

4D Molecular Therapeutics Inc的净融资是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，4D Molecular Therapeutics Inc的净融资为112.96M（同比变化-66.51）。

4D Molecular Therapeutics Inc的每股收益（EPS）是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，每股收益（EPS）为-2.42（同比变化18.90）。

4D Molecular Therapeutics Inc的净利润是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，净利润为-140.11M（同比变化12.90）。

4D Molecular Therapeutics Inc的净利润率是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，净利润率为-164.43（同比变化99.96）。

4D Molecular Therapeutics Inc的股东权益回报率（ROE）是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，股东权益回报率（ROE）为-27.57（同比变化29.86）。

4D Molecular Therapeutics Inc的资产回报率（ROA）是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，资产回报率（ROA）为-24.86（同比变化30.43）。

4D Molecular Therapeutics Inc的营业利润是多少？



根据4D Molecular Therapeutics Inc的FY2025财报，营业利润为-159.55M（同比变化15.06）。